CoChat

Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity

Open access

The DOI matches its Crossref record; 134 of the 137 references it cites were found in a registry or an index.

Abstract

Despite decades of unequivocal evidence that waist circumference provides both independent and additive information to BMI for predicting morbidity and risk of death, this measurement is not routinely obtained in clinical practice. This Consensus Statement proposes that measurements of waist circumference afford practitioners with an important opportunity to improve the management and health of patients. We argue that BMI alone is not sufficient to properly assess or manage the cardiometabolic risk associated with increased adiposity in adults and provide a thorough review of the evidence that will empower health practitioners and professional societies to routinely include waist circumference in the evaluation and management of patients with overweight or obesity. We recommend that decreases in waist circumference are a critically important treatment target for reducing adverse health risks for both men and women. Moreover, we describe evidence that clinically relevant reductions in waist circumference can be achieved by routine, moderate-intensity exercise and/or dietary interventions. We identify gaps in the knowledge, including the refinement of waist circumference threshold values for a given BMI category, to optimize obesity risk stratification across age, sex and ethnicity. We recommend that health professionals are trained to properly perform this simple measurement and consider it as an important ‘vital sign’ in clinical practice.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41574-019-0310-7

Cites

134 of 134 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 The prevalence of abdominal obesity and obesity measured in different studies. Changes in the prevalence of abdominal obesity (measured using waist circumference) and general obesity (measured using BMI) measured in different studies during the time period indicated on the x axis. General obesity was defined as BMI ≥30 kg/m2. Abdominal obesity was defined as waist circumference ≥88 cm and ≥102 cm for women and men, respectively. However, Xi et al. defined general obesity as BMI ≥28 kg/m2 and abdominal obesity as waist circumference ≥80 cm and ≥85 cm for Chinese women and men, respectively113. In addition, Barzin et al. defined general obesity as BMI ≥30 kg/m2 and abdominal obesity as waist circumference ≥91 cm and ≥89 cm for Iranian women and men, respectively114. Years given (for example, 1999–2011) indicate the years in which data were collected. F, female; M, male. Data are from refs37,113–121.
Fig. 1 The prevalence of abdominal obesity and obesity measured in different studies. Changes in the prevalence of abdominal obesity (measured using waist circumference) and general obesity (measured using BMI) measured in different studies during the time period indicated on the x axis. General obesity was defined as BMI ≥30 kg/m2. Abdominal obesity was defined as waist circumference ≥88 cm and ≥102 cm for women and men, respectively. However, Xi et al. defined general obesity as BMI ≥28 kg/m2 and abdominal obesity as waist circumference ≥80 cm and ≥85 cm for Chinese women and men, respectively113. In addition, Barzin et al. defined general obesity as BMI ≥30 kg/m2 and abdominal obesity as waist circumference ≥91 cm and ≥89 cm for Iranian women and men, respectively114. Years given (for example, 1999–2011) indicate the years in which data were collected. F, female; M, male. Data are from refs37,113–121.CC BY · PubMed Central
Fig. 2 Overview of potential role of functional and dysfunctional adipose tissue contributing to increased cardiometabolic risk. The ability of subcutaneous adipose tissue (SAT) to expand through hyperplasia (generation of new fat cells) allows the safe storage of the excess energy from the diet into a properly expanding subcutaneous ‘metabolic sink’. When this process becomes saturated or in situations where adipose tissue has a limited ability to expand, there is a spillover of the excess energy, which must be stored in visceral adipose tissue as well as in normally lean organs such as the skeletal muscle, the liver, the pancreas and the heart, a process described as ectopic fat deposition. Visceral adiposity is associated with a hyperlipolytic state resistant to the effect of insulin along with an altered secretion of adipokines including inflammatory cytokines whereas a set of metabolic dysfunctions are specifically associated with increased skeletal muscle, liver, pancreas, and epicardial, pericardial and intra-myocardial fat. FFA, free fatty acid.
Fig. 2 Overview of potential role of functional and dysfunctional adipose tissue contributing to increased cardiometabolic risk. The ability of subcutaneous adipose tissue (SAT) to expand through hyperplasia (generation of new fat cells) allows the safe storage of the excess energy from the diet into a properly expanding subcutaneous ‘metabolic sink’. When this process becomes saturated or in situations where adipose tissue has a limited ability to expand, there is a spillover of the excess energy, which must be stored in visceral adipose tissue as well as in normally lean organs such as the skeletal muscle, the liver, the pancreas and the heart, a process described as ectopic fat deposition. Visceral adiposity is associated with a hyperlipolytic state resistant to the effect of insulin along with an altered secretion of adipokines including inflammatory cytokines whereas a set of metabolic dysfunctions are specifically associated with increased skeletal muscle, liver, pancreas, and epicardial, pericardial and intra-myocardial fat. FFA, free fatty acid.CC BY · PubMed Central
Fig. 3 Waist circumference is a modifiable risk factor that can indicate cardiometabolic risk, morbidity and mortality. An illustration of the important role that decreases in waist circumference have for linking improvements in lifestyle behaviours with downstream reductions in the risk of morbidity and mortality. The benefits associated with reductions in waist circumference might be observed with or without a change in BMI.
Fig. 3 Waist circumference is a modifiable risk factor that can indicate cardiometabolic risk, morbidity and mortality. An illustration of the important role that decreases in waist circumference have for linking improvements in lifestyle behaviours with downstream reductions in the risk of morbidity and mortality. The benefits associated with reductions in waist circumference might be observed with or without a change in BMI.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

3 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 134 references

Research works printed but not linked: 1

  1. Hammond, B. P., Brennan, A. M. & Ross, R. in Body Composition: Health and Performance in Exercise and Sport (ed. Lukaski, H. C.) 109–128 (CRC Press, Taylor and Francis Group, 2017).

Cited by

See all 1,966

Metadata

Authors
Ross, R., Neeland, I. J., Yamashita, S., Shai, I., Seidell, J., Magni, P., Santos, R. D., Arsenault, B., Cuevas, A., Hu, F. B., Griffin, B. A., Zambon, A., Barter, P., Fruchart, J.-C., Eckel, R. H., Matsuzawa, Y., & Després, J.-P.
Affiliations
  • Queen's University (CA)
  • The University of Texas Southwestern Medical Center (US)
  • The University of Osaka (JP)
  • Ben-Gurion University of the Negev (IL)
  • University of Milan (IT)
  • Universidade de São Paulo (BR)
  • Clínica Las Condes (CL)
  • Harvard University (US)
  • University of Surrey (GB)
  • University of Padua (IT)
  • UNSW Sydney (AU)
  • Fondation Coeur et Artères (FR)
  • University of Colorado Anschutz (US)
  • Université Laval (CA)
Corresponding author
Ross, Robert
Venue
Nature Reviews Endocrinology
Published
2020-02-04
Volume
16
Issue
3
Pages
177-189
ISSN
  • 1759-5029 (ISSN-L)
  • 1759-5037
OpenAlex
W3004876731
Cited by
1,966
References
137
Citations by year
2026: 334 · 2025: 432 · 2024: 360 · 2023: 312 · 2022: 264 · 2021: 199 · 2020: 61
FWCI
31.97
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Reviews Endocrinology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • VU Research Portal (publishedVersion, other-oa)
  • Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
  • Open Research (University of Surrey) (submittedVersion, cc-by)
  • Padua Research Archive (University of Padova) (submittedVersion, cc-by)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
Funders
  • Université Laval
  • Indian Council for Cultural Relations
  • Canadian Institutes of Health Research (FDN- 167278)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
Keywords
waist circumference, visceral obesity, cardiometabolic risk, body mass index, vital signs, overweight, obesity treatment, exercise intervention, dietary intervention, adiposity
MeSH terms
Female, Humans, Male, Body Mass Index, Waist Circumference, Obesity, Abdominal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity. https://app.cochat.ai/papers/10.1038/s41574-019-0310-7
The paper
Ross, R., Neeland, I. J., Yamashita, S., Shai, I., Seidell, J., Magni, P., Santos, R. D., Arsenault, B., Cuevas, A., Hu, F. B., Griffin, B. A., Zambon, A., Barter, P., Fruchart, J.-C., Eckel, R. H., Matsuzawa, Y., & Després, J.-P. (2020). Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity. Nature Reviews Endocrinology. https://doi.org/10.1038/s41574-019-0310-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.